In conclusion, we demonstrated that expression levels of TFAP2B and AP-1 protein were increased while the expression levels of JAZF1 were decreased in papillary thyroid carcinoma in comparison with non-neoplastic thyroid tissues using immunohistochemistry. This evidence concerns the gene TFAP2B and thyroid gland papillary carcinoma.